Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PD-1 Knockout T Cells in Advanced NSCLC
NCT02793856Phase 1Completed
- Sponsor
- Sichuan University
- Start
- Aug 2016
- Primary completion
- Aug 2018
- Modality
- Gene Editing, Gene Silencing, Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label trial of pd-1 knockout t cells in non-small cell lung cancer (NSCLC) (3 arms), sponsored by Sichuan University. Primary endpoint: Adverse Events and Dose Limiting Toxicities at 6 months. Started Aug 2016; status: completed.
02
Drugs
pd-1 knockout t cells
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02793856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02793856.